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ABSTRACT	A	 review	was	made	of	 the	 records	of	 all	patients	with	pulmonary	 tuberculosis	 and	diabetes	
mellitus	 admitted	over	 a	 5-year	period	 to	 a	 teaching	hospital	 in	Karachi,	 Pakistan.	Among	42	358	pa-
tients,	 the	 total	number	with	both	 tuberculosis	and	diabetes	was	173.	The	prevalence	of	 tuberculosis	 in	
diabetic	patients	was	10-times	higher	 than	 in	non-diabetic	patients	and	prevalence	 increased	with	dura-
tion	of	diabetes.	The	 lower	 lung	 field	was	most	 frequently	 involved,	 followed	by	 the	upper	and	middle.	
Bilateral	 involvement	was	 seen	 in	half	 and	an	associated	pleural	 effusion	 in	one-third	of	 the	patients.	
Cavitating	lesions	were	seen	in	32%	of	men	and	15%	of	women.	
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Caractéristiques	 cliniques	 de	 la	 tuberculose	 pulmonaire	 chez	 des	 patients	 adultes	 pakistanais	
présentant	une	comorbidité	de	diabète	sucré
RÉSUMÉ	On	 a	 procédé	 à	 un	 examen	 des	 dossiers	 de	 tous	 les	 patients	 atteints	 de	 tuberculose	 pul-
monaire	 et	de	diabète	 sucré	qui	 ont	 été	 admis	dans	un	hôpital	 universitaire	de	Karachi	(Pakistan)	 sur	
une	période	de	5	ans.	 Sur	 les	42	358	patients,	 le	nombre	 total	de	patients	atteints	à	 la	 fois	de	 tubercu-
lose	 et	de	diabète	 s’élevait	 à	 173.	 La	prévalence	de	 la	 tuberculose	 chez	 les	patients	diabétiques	 était	
10	 fois	plus	élevée	que	chez	 les	patients	non	diabétiques	et	 la	prévalence	augmentait	 avec	 la	durée	du	
diabète.	 Le	 champ	pulmonaire	 inférieur	était	 le	plus	 fréquemment	atteint,	 suivi	par	 le	 champ	supérieur	
et	moyen.	On	 a	 noté	 une	 atteinte	bilatérale	 chez	 la	moitié	 des	 patients	 et	 un	 épanchement	pleural	
associé	 chez	 un	 tiers	 des	 patients.	Des	 lésions	 cavitaires	 ont	 été	 observées	 chez	 32	%	des	 hommes	
et	15	%	des	femmes.
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Introduction
Pulmonary tuberculosis (TB) and diabet
tes mellitus (DM) may coexist frequently, 
particularly in a population at high risk of 
acquiring TB. DM has been reported to 
modify the clinical features of TB. Comt
parative studies of TB in diabetics have 
provided conflicting results. In a recent 
study from Mexico, diabetic patients were 
older, had more lower lung field lesions 
and had more multiple cavities [1]. In a 
Turkish study, DM did not affect the pret
senting features of pulmonary TB and was 
only associated with more lower lung field 
disease in females and in older patients [2]. 
Another study from Saudi Arabia showed 
similar symptoms, radiographic distribution 
and cavitary disease in diabetic and nont 
diabetic patients with pulmonary TB [3]. 
Pulmonary TB may adversely affect 
glycaemic control. TB infection has been 
shown to produce glucose intolerance that 
improves or normalizes with antitTB treatt
ment [4]. This association is not specific to 
TB but is seen in other respiratory infections 
such as pneumonia [5]. Asian patients from 
the Indian subcontinent have a higher incit
dence of insulin resistance and associated 
complications [6]. There is little information 
on whether DM affects the presentation, 
radiographic manifestations and clinical 
course of pulmonary TB for Asian patients 
from the Indian subcontinent.
The aims of this study were to detert
mine whether DM alters the clinical and 
radiographic manifestations of pulmonary 
TB in Pakistani patients and to compare the 
prevalence of TB in hospitalized patients 
with and without DM. 
Methods
The study was a retrospective descriptive 
study conducted at The Aga Khan Univert
sity Hospital, a 450tbed teaching hospital 
in Karachi, Pakistan. The medical records 
were reviewed for all adult patients (aged 
14 years and above) with a diagnosis of both 
pulmonary TB and DM, admitted from Jant
uary 1992 to December 1996. Information 
about demographic data, clinical features, 
laboratory investigations and outcome of 
treatment were recorded. 
Patients with diabetes were included if 
they had a previous history of DM and were 
receiving antitdiabetic therapy at the time 
of hospital admission or were later found to 
have 2 or more fasting blood glucose levels 
greater than 140 mg/dL and started on antit
diabetic treatment. An aget and sextmatched 
group of nontdiabetic patients, who were 
hospitalized during the same time period, 
were used as the control group to estimate 
the prevalence of TB in nontdiabetics. 
The diagnosis of TB was based on a post
itive culture or histopathology, a suggestive 
serosal fluid report or typical radiographic 
findings with high clinical probability of 
TB. The data on radiographic findings were 
collected using the posterior–anterior roentt
genograms obtained at the time of diagnot
sis. In compliance with the usual clinical 
approach, the upper, mid and lower zones 
were defined by theoretical horizontal lines 
passing at the level of the anterior ends of 
the second and fourth ribs, respectively.
Statistical analysis (including prevat
lence rates) was performed using Epi-Info 
statistical software, version 6.0. Student’s 
tttest or chitsquared test were performed 
where applicable.
Results
A total of 42 358 patients were admitted to 
The Aga Khan University Hospital, between 
1992 and 1996. The number of patients dist
charged with a diagnosis of DM was 1458 
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and with a diagnosis of TB was 691. The 
total number of patients with both TB and 
DM were 173. The prevalence of TB in 
diabetic patients was 173/1458 (11.9%) and 
in nontdiabetic patients was 691/40 900 
(1.7%) (P < 0.5).
Data on 93 of the 173 patients (56 males, 
37 females) with both TB and DM was availt
able for analysis. The clinical characteristics 
of these patients are presented in Table 1. 
The majority of the patients (82%) were 
40–70 years of age, with only 6% below 40 
years and 12% above 70 years of age. The 
prevalence of TB increased progressively 
with the duration of DM (Table 1). 
The highest prevalence was in those with 
DM of more than 10 years duration. Most of 
the patients (80%) required oral hypoglyt
caemic agents and hence were classified as 
type 2 diabetics; about 9% required insulin 
and the remainder were diettcontrolled. 
Fever was the commonest presenting 
symptom of TB in this group, being high 
grade (> 38 ºC) in 55% of patients and 
of more than 3tmonths duration in 10% 
of patients. Positive auscultatory findings 
on chest examination were found in 84%, 
with bronchial breathing in 13%. We found 
43.0% of lower lobe, 20.3% upper lobe and 
only 15.0% middle lobe involvement on 
clinical examination. 
Chest radiograph findings are presented 
in Table 2 for the 77 patients for whom 
chest Xtrays were available (some Xtrays 
were unavailable for analysis as patients 
had been allowed to take the films). The 
lower lung fields were most frequently 
involved, followed by the upper and middle 
fields. Cavitating lesions were significantly 
more common in males (32%) than in fet
males (15%). Erythrocyte sedimentation 
Table	1	Clinical	characteristics	of	pulmonary	
tuberculosis	(TB)	patients	with	diabetes	
mellitus	(n	=	93)				
Characteristic	 Value
Patient	characteristics	 	 	
	 Male:	female	ratio	 3:2	 	
	 Mean	(range)	age	(years)	 46.1	 (20–90)	
	 Mean	(range)	duration	of		
	 diabetes	(years)		 13.8	 	(1–17)
	 	 																No.	 %
Duration	of	diabetes	(years)	 	 	
	 <	2	 	6		 7	
	 2–5		 14	 15	
	 5–10		 26	 28	
	 >10	 47	 51
Family	history	of	tuberculosis		 	 	
	 Yes	 10	 11
Presenting	symptoms	of	TB		 	 	
	 Fever		 67	 	72	
	 Cough	 61	 66	
	 Dyspnoea	 22	 	24	
	 Haemoptysis	 17	 18	
	 Weight	loss	 8	 9
Table	2	Chest	radiograph	findings	in	
pulmonary	tuberculosis	patients	with	
diabetes	mellitus	(n	=	77)			
Variable	 No.	 %
Side	affected		 	 	
	 Right	 31	 40	
	 Left	 10	 13	
	 Bilateral	 36	 47
Lung	field	affected	 	 	
	 Upper	only	 12	 18	
	 Middle	only	 10	 15	
	 Lower	only	 24	 36	
	 Upper	and	middle	 9	 13	
	 Upper,	middle	and	lower	 1	 1	
	 Upper	and	lower	 5	 7	
	 Middle	and	lower	 6	 9
Associated	features	 	 	
	 Effusion	 25	 32	
	 Cavity	 20	 26	
	 Hilar	lymphadenopathy	 4	 5
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rate (ESR) was checked in 61 patients and 
was < 100 mm/h in only 13 patients. Pleural 
biopsy was performed in 13/25 patients 
with pleural effusion and was diagnostic in 
11 patients. 
The number of patients who died was 10 
overall, giving a mortality rate in these 93 
patients with DM and TB of 11%.  Mortalt
ity was not influenced by the radiographic 
appearance. A high ESR (> 50 mm/h) was 
associated with a better outcome. The mean 
ESR for patients who died was 46 mm/h 
compared with 76 mm/h for patients who 
were cured.
The outcome of antitTB therapy was 
better in type 1 DM, when compared with 
type 2 DM with early clearance of bacilli 
and improvement in cavities: after 6 months 
5/9 (56%) patients with type 1 DM showed 
clearance of bacilli compared with 32/84 
(40%) patients with type 2 DM. 
Discussion
Our study describes the characteristics of 
pulmonary TB in Pakistani adult diabetics 
with a diagnosis of both TB and DM. In 
our hospitalized patients, TB prevalence 
was 11.9% in patients with DM, 10ttimes 
more common than in those without DM. 
In a large cohort of Korean diabetic patients 
(over 8000) the relative risk of developt
ing bacteriological confirmed pulmonary 
TB was 5 times higher in diabetics than in 
matched controls [6]. In a random sample 
of 100 Indian diabetic patients, TB was 
diagnosed by a positive sputum result in 
6% and by radiological examination in 27% 
[7]. In a 1–7 year followtup study of 1250 
African diabetic patients, 5.4% developed 
pulmonary TB [8]. The prevalence was 
higher in those with a lower body mass 
index, in type 1 DM compared with type 2 
DM and in those whose diabetes was poorly 
controlled.
The majority of our patients who develt
oped TB were middletaged (30–60 years), 
similar to other studies. In the Indian study, 
a majority of patients were above 40 years 
of age [7]. In both the Korean [6] and 
Japanese [9] studies, the prevalence was 
particularly high in the age groups 40–50 
years compared to the other age groups. In 
our study, the prevalence of TB increased 
progressively with duration of diabetes. The 
highest prevalence was seen in those who 
had been diagnosed with DM for more than 
10 years. Comparative studies of type 1 DM 
and type 2 DM have shown that the prevat
lence of type 1 DM was 8ttimes higher in 
TB patients than in the general population, 
whereas the prevalence of type 2 DM was 
similar [10]. TB patients with type 1 DM 
have a more acute course of TB, rapid 
progression, and formation of extensive let
sions with multiple cavities [11]. There was 
early clearance of bacilli and improvement 
in cavities in type 1 DM compared with type 
2 DM. 
The reason for increased susceptibility 
of diabetics to TB may be multifactorial. 
Alveolar macrophages play a critical role 
in eliminating mycobacterial infection in 
collaboration with lymphocytes. Alveolar 
macrophages have been found to be less act
tivated in TB patients complicated with DM 
which may contribute to increased susceptit
bility [12]. In a study of 64 TB patients with 
DM a higher depression of cellular immut
nity was evidenced by fewer T lymphocytes 
and their decreased capacity for blasttcell 
transformation than those with TB alone 
[13]. Differences in cytokine production 
have also been observed. Interferon (IFN)t
gamma production by CD4+ Ttcell was 
reduced in patients with TB but those with 
poor diabetic control produced significantly 
less IFNtgamma than did patients with good 
diabetic control. In a longitudinal study, 
IFNtgamma production returned to normal 
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by 6 months in patients with TB alone and 
in well controlled diabetic TB patients but 
remained suppressed in poorly controlled 
diabetic TB patients [8]. Changes in pulmot
nary vasculature and alveolar oxygen prest
sure may also be contributory. Histological 
features of disseminated microangiopathy 
were observed in the lung preparations of 
47 patients with destructive TB and DM 
[14].
The presence of DM does not seem to 
modify the presenting symptoms of pult
monary TB [2,3]. Fever with cough and 
sputum remain the common presenting 
features. Tuberculin reaction was found 
to be similar [2]. Data on bacteriological 
results are variable. Some studies showed 
no difference in bacteriology results, bacilli 
negative conversion rate or TB relapse rate 
in diabetic patients [14]. Other studies have 
shown that in diabetic patients the proport
tion of smear positive cases was higher, 
the culturetnegative conversion period was 
longer [15], relapse rates were higher [16] 
and TB relapses were frequently associated 
with resistant strains [14]. In a case–control 
study from New York the relative risk of 
multitdrug resistant TB was found to be 
8.6 (confidence interval, 3.1 to 23.6) in the 
diabetic group compared with the control 
group [17]. In patients with pulmonary TB, 
the most common underlying disease was 
DM [15]. In an innertcity cohort, presence 
of underlying illness (DM, chronic obstruct
tive pulmonary disease, renal failure) and 
immunosuppression were important predict
tors of survival for patients with pulmonary 
TB [18]. 
Upper zone involvement and presence 
of cavitations are typical features of active 
pulmonary TB. In patients with DM and 
other systemic diseases, chest radiograph 
changes may be atypical. In our study, 
lower lung field involvement was the most 
frequent change, with upper and middle 
changes less common. Bilateral changes 
were present in half of the patients and an 
associated effusion was present in onet
third. In a comparative study of pulmonary 
TB patients with and without DM, being a 
diabetic was found to be the most important 
factor determining lower lung field lesions 
[1]. In a second study, lower lung field TB 
was only seen in older diabetic patients 
(above 40 years) and female sex [2]. Other 
studies have, however, failed to show any 
differences in localization of TB lesions 
[3,19]. Cavitation was seen in only 26% 
of our patients. A higher rate of multiple 
cavitation has been reported in many studt
ies [1,2,19] but not in others [3]. Among 
diabetics, patients with type 1 diabetes were 
found to have more extensive lesions with 
multiple cavities [11]. 
In conclusion, pulmonary TB may occur 
more often among patients with diabetics 
than those without, mostly between 40 and 
70 years of age. Fever and cough are the 
common presenting symptoms. Lower lung 
field and bilateral or multitlobar involvet
ment is common. An associated effusion 
may be present. The mortality rate was 10% 
but was not associated with a particular 
radiographic appearance.
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